跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,362 条关于
“MT-ND4”
全部
1,362
临床试验
608
药物
456
机构
7
资讯
291
去年
GenSight's Gene Therapy Shows Better Outcomes When Administered During Dynamic Phase of LHON Disease
2个月前
FDA Probes Sevoflurane-Linked Neurological Complications in Patients of Venezuelan Ancestry
去年
Lenadogene Nolparvovec Shows Sustained Vision Improvement in LHON Patients After 5 Years
去年
Marker Therapeutics Reports Positive Clinical Outcomes for MT-601 in Lymphoma Patients
去年
Myeloid Therapeutics' MT-303, a Novel mRNA CAR Therapy, Enters Phase 1 Trial for Liver Cancer
去年
Marker Therapeutics' MT-601 Shows 78% Response Rate in Refractory Lymphoma Patients
去年
PROTECT-MT Trial Suggests Worse Outcomes with Balloon Guide Catheters in Stroke Thrombectomy
9个月前
CREATE Medicines Initiates First-in-Class Frontline HCC Trial Combining In Vivo CAR Therapy MT-303 with Standard Immunotherapy
4个月前
Curacle and Maptics License Bispecific Antibody MT-103 to Memento Medicines in $1.08 Billion Deal for Retinal Disease Treatment
2年前
PharmAla Biotech to Supply LaNeo MDMA for Clinical Trials at Mt. Sinai, Harvard, and Johns Hopkins
第 1 页,共 30 页
上一页
下一页